BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
CXCL2
,
G-protein-coupled receptor binding
,
Obesity
,
Liver
,
Avian flu virus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
B-1a B cell differentiation
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Bone marrow
Spleen
Lymph nodes
Stomach pyloric
Esophagus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Toxic nephropathy
Mucopolysaccharidosis
Methicillin resistant Staphylococcus aureus infection
Transplanted organ rejection
Alpha-1-antitrypsin deficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Butylhydroxybutylnitrosamine
P79 protein, human
Complement C1q
Niacinamide
anthrax lethal factor
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR585
USP27X
FNIP1
TLR5
mir-124
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Embryonic stem J1 cells expressing Mettl3 or Mettl14 shRNA
C1q elicited macrophage gene expression
Bladder cancer prevention using nicotinamide
SCC7 and NR-S1 murine tumors after C-ion or gamma irradiation
Lungs from TNFRSF1A/1B knockout and wildtype mice infected with pathogenic SARS MA15 virus
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for B-1a B cell differentiation
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressi…
Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protei…
Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or …
Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ